TXG
Technology10x Genomics Inc - Class A
Live · NASDAQ · May 9, Close
What's Moving TXG Today?
No stock-specific AI insight has been generated for TXG yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
TXG News
21 articles- 10x Genomics (TXG) Q1 2026 Earnings TranscriptMotley Fool·May 7, 2026
- 10x Genomics (TXG) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesYahoo Finance·May 7, 2026
- 10x Genomics (TXG) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 7, 2026
- 10x Genomics’s (NASDAQ:TXG) Q1 CY2026: Beats On Revenue But Stock DropsYahoo Finance·May 7, 2026
- 10x Genomics Reports First Quarter 2026 Financial ResultsYahoo Finance·May 7, 2026
- PacBio Pre-Q1 Analysis: Time to Buy, Hold or Sell the Stock Now?Yahoo Finance·May 5, 2026
- Should Launch of Atera Spatial Biology Platform Require Action From 10x Genomics (TXG) Investors?Yahoo Finance·May 3, 2026
- 10x Genomics (TXG) Expected to Beat Earnings Estimates: Should You Buy?Yahoo Finance·Apr 30, 2026
- 10x Genomics to Participate in the BofA Securities 2026 Healthcare ConferenceYahoo Finance·Apr 29, 2026
- 1 Unprofitable Stock to Target This Week and 2 That UnderwhelmYahoo Finance·Apr 29, 2026
- Tempus AI Stock Before Q1 Earnings Release: To Buy or Not to Buy?Yahoo Finance·Apr 27, 2026
- 1 Cash-Heavy Stock to Target This Week and 2 We IgnoreYahoo Finance·Apr 25, 2026
- Why 10x Genomics (TXG) Shares Are Trading Lower TodayYahoo Finance·Apr 24, 2026
- LiquidCell Dx Appoints Former Foundation Medicine, 10x Genomics and IDT Leader Mirna Jarosz as Chief Executive Officer; Names Former Foundation Medicine Chief Medical Officer Vincent A. Miller, MD, Senior Strategic AdvisorYahoo Finance·Apr 23, 2026
- 10x Genomics Stock Up on Atera Launch, Spatial Biology Scale EnhancedYahoo Finance·Apr 20, 2026
- Here's How Zimmer Biomet Is Placed Ahead of Q1 EarningsYahoo Finance·Apr 20, 2026
- 10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and UnderstoodYahoo Finance·Apr 19, 2026
- 3 Overrated Stocks We Keep Off Our RadarYahoo Finance·Apr 17, 2026
- 10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026Yahoo Finance·Apr 15, 2026
- Keys to Succeed in the Booming $300 Million Optical Genome Mapping Market 2026-2030: Bionano Genomics, 10x Genomics, and Oxford Nanopore Technologies LeadYahoo Finance·Apr 13, 2026
- Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - Asia-Pacific NGS Market Poised for Fastest Growth, Driven by Large-Scale Genomic Projects and the Rising Need for Precision MedicineGlobeNewswire Inc.·Apr 10, 2026
All 21 articles loaded
Price Data
Fundamentals
Trading
About 10x Genomics Inc - Class A
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).